PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1
Cell Proliferation · 2026-03 · 59 (3)
DOI: 10.1111/cpr.70101 ↗At a glance
Journal article in Cell Proliferation, published online on 2025-07-31. Written by Dongdong Xie and 8 co-authors. Institution: Department of Urology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. Major MEDLINE topics: Carcinoma, Renal Cell, Cuproptosis, Thiamine, Hydrazines. Cited 8 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.
Abstract (original language)
Cuproptosis, a copper‐dependent cell death mechanism driven by tricarboxylic acid (TCA) cycle collapse, shows limited efficacy in hypoxic or glycolytic renal cell carcinoma (RCC). Here, through systematic screening of 688 glycolysis inhibitors combined with elesclomol (ES), we identified PIK‐III as a potent cuproptosis sensitiser. Multi‐omics analysis revealed that PIK‐III restores sensitivity by rewiring thiamine metabolism. Mechanistically, PIK‐III induces macropinocytosis, enabling thiamine uptake to replenish thiamine pyrophosphate (TPP), which activates pyruvate dehydrogenase E1‐alpha 1 (PDHA1) and redirects pyruvate into the TCA cycle. Concurrently, ES‐induced DLAT oligomerisation disrupts TCA flux, creating a metabolic crisis. In vivo, PIK‐III synergises with ES to suppress tumour growth in xenograft and patient‐derived models without systemic toxicity. Our work uncovers a metabolic vulnerability in cuproptosis‐resistant RCC and positions PIK‐III as a therapeutic candidate to overcome resistance via dual targeting of thiamine transport and mitochondrial dysfunction.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Urology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
- Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
- Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
- Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
ORCID profiles: Dongdong Xie, Yingbo Dai
Funding
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
Cite
APA
Xie, D., Wang, Y., Cheng, W., Yan, M., Li, K., Wu, X., Wu, J., Zhang, Z., & Dai, Y. (2026). PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1. Cell Proliferation, 59(3). https://doi.org/10.1111/cpr.70101
Vancouver
Xie D, Wang Y, Cheng W, Yan M, Li K, Wu X, et al. PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1. Cell Proliferation. 2026;59(3). doi:10.1111/cpr.70101
BibTeX
@article{Xie2026,
author = {Xie, Dongdong and Wang, Yu and Cheng, Wenjie and Yan, Minbo and Li, Kunyu and Wu, Xiang and Wu, Jiaqing and Zhang, Zhuangzhuang and Dai, Yingbo},
title = {PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1},
journal = {Cell Proliferation},
year = {2026},
volume = {59},
number = {3},
doi = {10.1111/cpr.70101}
}
EUVIMED